In renal cancer emerging treatment options are becoming available and there is a strong need to combine therapies to reformulate and adjourn clinical practice. We here highlight and discuss the need to take advantage of the common immune targets to design combined strategies to increase clinical responses.
Cancer treatment reviews. 2018 Jul 26 [Epub ahead of print]
M Nuti, I G Zizzari, A Botticelli, A Rughetti, P Marchetti
Department of Experimental Medicine, University Sapienza, Rome, Italy. Electronic address: ., Department of Experimental Medicine, University Sapienza, Rome, Italy., Department of Clinical and Molecular Medicine, University Sapienza, Rome, Italy.